Are Neutropenic Diets Beneficial to Improve Outcome?
This study is comparing two different diets. The cooked group will be allowed to eat only
cooked food and cooked fruits or vegetables. The raw group will be able to eat cooked food
and the addition of fresh fruits and vegetables. Patients will be monitored for infection
in both groups. There are still certain foods that you are restricted from eating while
receiving chemotherapy and you will be given a list of these restrictions.
If you agree to take part in this study, you will be randomly assigned (as in the flip of a
coin) to 1 of 2 groups.
Group 1: Raw group: You will be asked to eat at least 1 raw fruit or vegetable every day
you are on study.
Group 2: Cooked group: You will eat only cooked foods while on study. The study doctor
will give you a list of the foods that you are allowed to eat.
Your medical chart will be monitored while you are on study to check how often you need
antibiotics to treat fever. or if you have an infection.
You will be asked to fill out a diet questionnaire every week. The questionnaire will have
5 questions about the foods you have been eating. If you have been released from the
hospital, you can return the questionnaire during your scheduled hospital visits,which
typically take place 3 times per week. You will have no additional visits during this study.
The questionnaire should take about 1-2 minutes each time.
Length of Study:
You will be taken off study if your white blood cell count returns to normal. If your white
blood cell counts do not return to normal, the maximum time that you may be on study is 6
This is an investigational study. There has not been enough research to prove if raw
fruits and vegetables can increase your risk of infection. Many hospitals allow
neutropenic patients to eat raw fruits and vegetables and other hospitals restrict fresh
fruits and vegetables but, this has not been adequately investigated.
Up to 128 patients will take part in this study. All will be enrolled at M. D. Anderson.
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label
Alison E Gardner, PhD
M.D. Anderson Cancer Center
United States: Institutional Review Board
|U.T. M.D. Anderson Cancer Center||Houston, Texas 77030|